Grzegorz S. Nowakowski

发表

Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.

Nadine J Barrett, W. McCaskill-Stevens, E. Yang, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

R. Gascoyne, D. Scott, M. Czuczman, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evolution: IMiDs to PPMs, revolution in DLBCL?

G. Nowakowski, Grzegorz S. Nowakowski, 2015, Blood.

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

J. Cerhan, T. Habermann, S. Ansell, 2023, Blood cancer journal.

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma

J. Cerhan, T. Habermann, S. Ansell, 2021, Blood cancer journal.

Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials

Michael L. Wang, T. Habermann, Shouhao Zhou, 2022, Blood Cancer Journal.

Diffuse large B-cell lymphoma: new targets and novel therapies

G. Salles, B. Cheson, G. Nowakowski, 2021, Blood Cancer Journal.

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study

T. Habermann, S. Ansell, T. Witzig, 2021, Blood Cancer Journal.

Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma

J. Cerhan, L. Sehn, M. Maurer, 2022, American journal of hematology.

Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era

J. Cerhan, A. Feldman, S. Slager, 2023, Blood cancer journal.

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

D. Scott, J. Friedberg, J. Leonard, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

J. Cerhan, G. Salles, A. Feldman, 2021, Blood Cancer Journal.

Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care

J. Cerhan, T. Habermann, A. Dispenzieri, 2022, JCO oncology practice.